Bone Biologics (BBLG) Return on Assets (2016 - 2017)
Bone Biologics (BBLG) has disclosed Return on Assets for 2 consecutive years, with 7.08% as the latest value for Q3 2017.
Bone Biologics (BBLG) has disclosed Return on Assets for 2 consecutive years, with 7.08% as the latest value for Q3 2017.